John Wisler, PH.D., DABT
Vice President, Toxicology and Pharmacology
Dr. John Wisler joined AnaptysBio as Vice President, Pharmacology and Toxicology in June 2020. He has more than 30 years of industry experience leading over 40 nonclinical drug development projects ranging from discovery safety evaluations through post marketing regulatory activities for both large and small molecule modalities. John’s extensive experience includes non-clinical drug development of oncology, inflammation, cardiology, and neurology therapeutics. Prior to AnaptysBio, he was Vice President of Toxicology and Pharmacokinetics at Calibr at Scripps Research, and has previously held roles of increasing seniority at Dart Neuroscience, Amgen, Allergan and Proctor & Gamble. He received his Ph.D.in Toxicology at Indiana University, earned his Diplomate of the American Board of Toxicology (DABT) and was a post-doctoral fellow at the US Army Medical Research Institute of Chemical Defense.